A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)

Clinical trial NCT07506863 · RECRUITING

Trial details

NCT number: NCT07506863
Sponsor: Agios Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Transfusion-dependent Alpha-Thalassemia Transfusion-dependent Beta-Thalassemia

Start date: 2026-09-01
Primary completion: 2029-06-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.